Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology

Buccal drug delivery combines the advantage of enhanced patient acceptance/ compliance of oral delivery, with overcoming drug degradation and poor absorption in the gastro intestinal tract (GIT), especially for large molecule therapeutics, such as insulin. Orally disintegrating tablets (ODTs) that d...

Full description

Bibliographic Details
Main Author: Iyire, Affiong
Published: Aston University 2016
Subjects:
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.705187
id ndltd-bl.uk-oai-ethos.bl.uk-705187
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-7051872018-07-10T03:12:41ZBuccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technologyIyire, Affiong2016Buccal drug delivery combines the advantage of enhanced patient acceptance/ compliance of oral delivery, with overcoming drug degradation and poor absorption in the gastro intestinal tract (GIT), especially for large molecule therapeutics, such as insulin. Orally disintegrating tablets (ODTs) that dissolve rapidly in the mouth, are gaining widespread popularity, especially with extreme populations, including children and the elderly. This project unifies the advantages of buccal drug delivery with that of ODTs, with the view to developing a non-invasive delivery system for proteins like insulin. This work was carried out in three parallel streams: A Quality by Design (QbD) based characterisation of excipients to identify and predict multi-functional behaviours as binder/ disintegrant/ mucoadhesive agent in ODT formulations; the investigation of a cost effective and easily reproducible cell culture based in vitro method for assessment of buccal delivery; and protein characterisation followed by an in vitro investigation of the effect of basic and acidic amino acids on the solubility, permeability, mechanism and transport route of insulin through TR146 buccal cell culture layers as safe and effective alternative permeation enhancers for proteins. D-mannitol based tablets containing 7% low-substituted hydroxypropyl cellulose (LHPC) with 1.3 % Polyox™ polymers compacted at 30 kN were able to maintain high mechanical properties with fast disaggregation of tablets and mucoadhesive properties. Addition of 1.2 to 1.5 mM Ca2+ to cell culture media was found to increase culture stratification, forming a tighter barrier to paracellular transport of macromolecules, to mimic in vivo barriers. Amino acids were able to significantly enhance insulin solubility in water, and exhibited a concentration-dependent enhancement of insulin permeability (over 400% enhancement) in vitro. Interestingly, results revealed that insulin was transported by an active transcellular process, probably provided by the presence of insulin receptors and amino acid nutrient transporters on the cell membrane. This result obtained for insulin is the first indication of a possible amino acid mediated transport of insulin via formation of insulin-amino acid neutral complexes by ion pairing.615.1Aston Universityhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.705187http://publications.aston.ac.uk/30165/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 615.1
spellingShingle 615.1
Iyire, Affiong
Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology
description Buccal drug delivery combines the advantage of enhanced patient acceptance/ compliance of oral delivery, with overcoming drug degradation and poor absorption in the gastro intestinal tract (GIT), especially for large molecule therapeutics, such as insulin. Orally disintegrating tablets (ODTs) that dissolve rapidly in the mouth, are gaining widespread popularity, especially with extreme populations, including children and the elderly. This project unifies the advantages of buccal drug delivery with that of ODTs, with the view to developing a non-invasive delivery system for proteins like insulin. This work was carried out in three parallel streams: A Quality by Design (QbD) based characterisation of excipients to identify and predict multi-functional behaviours as binder/ disintegrant/ mucoadhesive agent in ODT formulations; the investigation of a cost effective and easily reproducible cell culture based in vitro method for assessment of buccal delivery; and protein characterisation followed by an in vitro investigation of the effect of basic and acidic amino acids on the solubility, permeability, mechanism and transport route of insulin through TR146 buccal cell culture layers as safe and effective alternative permeation enhancers for proteins. D-mannitol based tablets containing 7% low-substituted hydroxypropyl cellulose (LHPC) with 1.3 % Polyox™ polymers compacted at 30 kN were able to maintain high mechanical properties with fast disaggregation of tablets and mucoadhesive properties. Addition of 1.2 to 1.5 mM Ca2+ to cell culture media was found to increase culture stratification, forming a tighter barrier to paracellular transport of macromolecules, to mimic in vivo barriers. Amino acids were able to significantly enhance insulin solubility in water, and exhibited a concentration-dependent enhancement of insulin permeability (over 400% enhancement) in vitro. Interestingly, results revealed that insulin was transported by an active transcellular process, probably provided by the presence of insulin receptors and amino acid nutrient transporters on the cell membrane. This result obtained for insulin is the first indication of a possible amino acid mediated transport of insulin via formation of insulin-amino acid neutral complexes by ion pairing.
author Iyire, Affiong
author_facet Iyire, Affiong
author_sort Iyire, Affiong
title Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology
title_short Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology
title_full Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology
title_fullStr Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology
title_full_unstemmed Buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology
title_sort buccal transmucosal delivery of large molecule therapeutics using orally disintegrating tablet technology
publisher Aston University
publishDate 2016
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.705187
work_keys_str_mv AT iyireaffiong buccaltransmucosaldeliveryoflargemoleculetherapeuticsusingorallydisintegratingtablettechnology
_version_ 1718711321349849088